Kyprolis 30 mg (Carfilzomib POWDER FOR SOLUTION) 30 MG

KYPROLIS 30 MG is a powder for solution used in intravenous therapy. This medication is designed to support specific therapeutic needs, often discussed with healthcare providers.

Strength

30 MG

Pack Size

30ML

Manufacturer / TM Owner

AMGEN CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KYPROLIS 30 MG is primarily used in the management of certain hematological conditions. It is a powder for solution that is administered intravenously. Patients often inquire about what KYPROLIS 30 MG is used for, and it is generally prescribed for conditions that require targeted therapy.

Side Effects

Common effects of KYPROLIS 30 MG may include fatigue, nausea, and anemia. These effects can vary among individuals and should be discussed with a healthcare professional. Patients may experience different responses based on their specific health conditions.

Precautions & Warnings

KYPROLIS 30 MG should be handled with care, following the instructions provided by a healthcare professional. It is important to store and administer this medication as directed to ensure safety and effectiveness. Patients should be aware of any potential allergies or sensitivities before use.

Avoid Interactions

KYPROLIS 30 MG may interact with certain medications, including those that affect liver enzymes. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances may also impact the effectiveness of KYPROLIS 30 MG.

Frequently Asked Questions

KYPROLIS 30 MG is used in the management of certain hematological conditions. It is typically prescribed by healthcare providers for targeted therapy.

KYPROLIS 30 MG is a powder for solution that is administered intravenously. The specific administration details should be discussed with a healthcare professional.

Common effects may include fatigue, nausea, and anemia. These effects can vary among individuals and should be discussed with a healthcare provider.

Yes, KYPROLIS 30 MG should be handled with care and administered as directed by a healthcare professional. Patients should be aware of any potential allergies or sensitivities.

Yes, KYPROLIS 30 MG may interact with certain medications, including those that affect liver enzymes. It is important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.